ConductScience.org, home

Genes

Open

193,990 genes from NCBI Gene. Counted 2026-11-11.

193,990 genes

Most papers first1,821 to 1,840 of 193,990

Show the results as
GeneNCBI GeneProteinsPatentsDrugsTrialsNIH grantsPapers
TRAJ60

T cell receptor alpha joining 60 (pseudogene)

28695

HGNC:12093

00002,8453,708
ACP3

acid phosphatase 3

55

HGNC:125

11171341,2903,704
FLNC

filamin C

2318

HGNC:3756

134002,1703,704
GLI3

GLI family zinc finger 3

2737

HGNC:4319

135002,2743,698
TFF1

trefoil factor 1

7031

HGNC:11755

1106001,9593,695
IFIT2

interferon induced protein with tetratricopeptide repeats 2

3433

HGNC:5409

121002,8043,694
SYN1

synapsin I

6853

HGNC:11494

120003,3193,694
CBFB

core-binding factor subunit beta

865

HGNC:1539

133001,8083,690
IL33R

interleukin 33 receptor

9173

HGNC:5998

1120162,7213,690
SFTPB

surfactant protein B

6439

HGNC:10801

175002,1563,679
NECTIN1

nectin cell adhesion molecule 1

5818

HGNC:9706

151002,4643,675
RAD51C

RAD51 paralog C

5889

HGNC:9820

126001,6503,668
IGF2BP2

insulin like growth factor 2 mRNA binding protein 2

10644

HGNC:28867

127001,7113,666
CD244

CD244 molecule

51744

HGNC:18171

1102002,3893,665
FGF4

fibroblast growth factor 4

2249

HGNC:3682

1165002,0543,660
CASP6

caspase 6

839

HGNC:1507

1751111,7193,659
SIN3A

SIN3 transcription regulator family member A

25942

HGNC:19353

125002,8933,655
FGA

fibrinogen alpha chain

2243

HGNC:3661

11365401,5343,650
HSD11B2

hydroxysteroid 11-beta dehydrogenase 2

3291

HGNC:5209

115101,7553,649
MIR27B

microRNA 27b

407019

HGNC:31614

00001,3743,646

Request

GET /api/genes/v1

A gene symbol, alias or name, an NCBI Gene, HGNC, Ensembl or UniProt ID, or a drug's name or ChEMBL ID.

No key needed

Response

The first 2 of this page's 20 results. GET /api/genes/v1?page=92

{
  "data": {
    "total": 193990,
    "results": [
      {
        "id": "28695",
        "title": "TRAJ60: T cell receptor alpha joining 60 (pseudogene)",
        "summary": "NCBI Gene 28695. 0 proteins, 0 patents, 0 drugs, 0 trials, 2,845 NIH grants and 3,708 papers.",
        "record": "/library/genes/28695",
        "gene_id": 28695,
        "symbol": "TRAJ60",
        "name": "T cell receptor alpha joining 60 (pseudogene)",
        "hgnc_id": "HGNC:12093",
        "counts": {
          "proteins": 0,
          "patents": 0,
          "drugs": 0,
          "trials": 0,
          "grants": 2845,
          "papers": 3708
        }
      },
      {
        "id": "55",
        "title": "ACP3: acid phosphatase 3",
        "summary": "NCBI Gene 55. 1 protein, 117 patents, 1 drug, 34 trials, 1,290 NIH grants and 3,704 papers.",
        "record": "/library/genes/55",
        "gene_id": 55,
        "symbol": "ACP3",
        "name": "acid phosphatase 3",
        "hgnc_id": "HGNC:125",
        "counts": {
          "proteins": 1,
          "patents": 117,
          "drugs": 1,
          "trials": 34,
          "grants": 1290,
          "papers": 3704
        }
      }
    ],
    "columns": [
      {
        "key": "symbol",
        "label": "Gene",
        "under": "name"
      },
      {
        "key": "id",
        "label": "NCBI Gene",
        "under": "hgnc_id"
      },
      {
        "key": "counts.proteins",
        "label": "Proteins"
      },
      {
        "key": "counts.patents",
        "label": "Patents"
      },
      {
        "key": "counts.drugs",
        "label": "Drugs"
      },
      {
        "key": "counts.trials",
        "label": "Trials"
      },
      {
        "key": "counts.grants",
        "label": "NIH grants"
      },
      {
        "key": "counts.papers",
        "label": "Papers"
      }
    ],
    "order": "Most papers first"
  },
  "release": "gene-search-2026-11-11-0.2.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ChEMBL, through Open Targets",
      "license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC BY-SA 3.0"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
      "short": "No license stated"
    },
    {
      "source": "EMBL-EBI's patent proteins",
      "license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
      "notice": null,
      "short": "No added restrictions. Attribution expected"
    },
    {
      "source": "GenBank's patent files",
      "license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
      "notice": null,
      "short": "No restrictions from NCBI. Submitters may hold rights"
    },
    {
      "source": "HGNC",
      "license": "CC0: https://www.genenames.org/about/license/",
      "notice": null,
      "short": "CC0"
    },
    {
      "source": "NCBI Gene",
      "license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
      "notice": null,
      "short": "Public domain (US government)"
    },
    {
      "source": "NIH's project files and grant-paper links",
      "license": "Public domain (NIH RePORTER)",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "Open Targets",
      "license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
      "notice": null,
      "short": "CC0 1.0"
    },
    {
      "source": "PubMed",
      "license": "NLM's terms",
      "notice": null,
      "short": "NLM's terms"
    },
    {
      "source": "PubTator 3",
      "license": "Public domain",
      "notice": null,
      "short": "Public domain"
    },
    {
      "source": "UniProt",
      "license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
      "notice": null,
      "short": "CC BY 4.0"
    }
  ],
  "next": "/api/genes/v1?page=93",
  "request_id": "VTZ8cRUDM8djqE8Y"
}
gene-search-2026-11-11-0.2.0Next page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

Trials

ClinicalTrials.gov

Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.

Open611,552 trials2026-11-12

Trial comparisons

ClinicalTrials.gov

Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.

Open85,013 comparisons2026-11-10

Sequences

Patent publications

Paste a sequence and see the patents that disclose it.

For invited accounts.

Opens sequences.conductscience.org

By invitation39,249,078 sequences2026-11-05

For software

Read Genes from software.

Every answer on this page is also JSON, under /api/genes/v1. No key.

GET https://conductscience.org/api/genes/v1?q=p53

Ask an assistant

  • Which drugs act on PCSK9, and which of their trials posted results?
  • How many patents list the exact protein sequence of TP53?
  • Which genes does evolocumab act on?
  • Which NIH grants have the most papers about APOE?